Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis.

Idiopathic Pulmonary Fibrosis Immune System Monocytes Regulatory T Cells Single-cell RNA Sequencing

Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
08 May 2024
Historique:
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 8 5 2024
Statut: aheadofprint

Résumé

Changes in peripheral blood cell populations have been observed but not detailed at single-cell resolution in idiopathic pulmonary fibrosis (IPF). To provide an atlas of the changes in the peripheral immune system in stable and progressive IPF. Peripheral blood mononuclear cells (PBMCs) from IPF patients and controls were profiled using 10x Chromium 5' single-cell RNA sequencing (scRNA-seq). Flow cytometry was used for validation. Protein concentrations of Regulatory T-cells (Tregs) and Monocytes chemoattractants were measured in plasma and lung homogenates from patients and controls. Thirty-eight PBMC samples from 25 patients with IPF and 13 matched controls yielded 149,564 cells that segregated into 23 subpopulations. Classical monocytes were increased in progressive and stable IPF compared to controls (32.1%, 25.2%, 17.9%, respectively, p<0.05). Total lymphocytes were decreased in IPF vs controls, and in progressive vs stable IPF (52.6% vs 62.6%, p=0.035). Tregs were increased in progressive vs stable IPF (1.8% vs 1.1% of all PBMC, p=0.007), although not different than controls, and may be associated with decreased survival (P=0.009 in Kaplan-Meier analysis; P=0.069 after adjusting for age, sex, and baseline FVC). Flow cytometry analysis confirmed this finding in an independent cohort of IPF patients. Fraction of Tregs out of all T cells was also increased in two cohorts of lung scRNA-seq. CCL22 and CCL18, ligands for CCR4 and CCR8 Treg chemotaxis receptors, were increased in IPF. The single-cell atlas of the peripheral immune system in IPF, reveals an outcome-predictive increase in classical monocytes and Tregs, as well as evidence for a lung-blood immune recruitment axis involving CCL7 (for classical monocytes) and CCL18/CCL22 (for Tregs).

Identifiants

pubmed: 38717443
doi: 10.1164/rccm.202306-0979OC
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Avraham Unterman (A)

Tel Aviv Sourasky Medical Center, 26738, Institute of Pulmonary Medicine, Tel Aviv, Israel.
Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Amy Y Zhao (AY)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Nir Neumark (N)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Jonas C Schupp (JC)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.
Hannover Medical School, 9177, Department of Respiratory Medicine, Hannover, Germany.

Farida Ahangari (F)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Carlos Cosme (C)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Prapti Sharma (P)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Jasper Flint (J)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Yan Stein (Y)

Tel Aviv Sourasky Medical Center, 26738, Institute of Pulmonary Medicine, Tel Aviv, Israel.

Changwan Ryu (C)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Genta Ishikawa (G)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Tomokazu S Sumida (TS)

Yale School of Medicine, 12228, Department of Neurology, New Haven, Connecticut, United States.

Jose L Gomez (JL)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Jose D Herazo-Maya (JD)

University of South Florida College of Medicine, 33697, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine , Tampa, Florida, United States.

Charles S Dela Cruz (CS)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Erica L Herzog (EL)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States.

Naftali Kaminski (N)

Yale School of Medicine, 12228, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, New Haven, Connecticut, United States; naftali.kaminski@yale.edu.

Classifications MeSH